Release Notes: Version 20220811
About this release
This release (version 20220811) provides the latest updates to the Canadian Clinical Drug Data Set in English and French. A separate InfoScribe location for the French supporting documents, including the French Release Notes, can be found here.
There is no change to the Technical Specification or the Editorial Guidelines.
The Canadian Clinical Drug Data Set is available for browsing and download via the Infoway Terminology Gateway.
Supporting general information can be found on Infoway Canadian Clinical Drug Data Set InfoCentral page.
General Notes
The following files are available as full release files within this version:
- Manufactured Product,
- Non-proprietary Therapeutic Product,
- Therapeutic Moiety,
- Manufactured Product-Non-proprietary Therapeutic Product-Therapeutic Product Relationship, in English (MP-NTP-TM Relationship),
- Manufactured Product-Non-proprietary Therapeutic Product-Therapeutic Product Relationship, in French (Relation PM-PTC-FT),
- Special Groupings,
- Coded Attribute, and
- Device Non-proprietary Therapeutic Product.
The "Full" release contains one entry for every concept that has ever been released and new content added for that release. New content added for a specific release may at times include “Inactive” content.
NOTE: The “Delta" release which is intended to contain only those concepts that have been added or changed since the previous release will be considered for a future enhancement at a later date.
This release reflects additions and changes that have occurred in DPD since the last CCDD release.
Change in Nomenclature
There has been a change in preferred name from scopolamine butylbromide TO hyoscine butylbromide. The following TM, NTP and MP concepts are affected with no change in codes.
CCDD Type | Code | Previous formal_name | Previous fr_description | New formal_name | New fr_description |
|---|---|---|---|---|---|
TM | 8001482 | scopolamine butylbromide | butylbromure de scopolamine | hyoscine butylbromide | butylbromure d'hyoscine |
NTP | 9001758 | scopolamine butylbromide 10 mg oral tablet | butylbromure de scopolamine 10 mg comprimé oral | hyoscine butylbromide 10 mg oral tablet | butylbromure d'hyoscine 10 mg comprimé oral |
NTP | 9012818 | scopolamine butylbromide 20 mg per 1 mL solution for injection ampoule | butylbromure de scopolamine 20 mg par 1 mL solution injectable ampoule | hyoscine butylbromide 20 mg per 1 mL solution for injection ampoule | butylbromure d'hyoscine 20 mg par 1 mL solution injectable ampoule |
NTP | 9012819 | scopolamine butylbromide 20 mg per 1 mL solution for injection vial | butylbromure de scopolamine 20 mg par 1 mL solution injectable fiole | hyoscine butylbromide 20 mg per 1 mL solution for injection vial | butylbromure d'hyoscine 20 mg par 1 mL solution injectable fiole |
MP | 02512335 | ACCEL-HYOSCINE (scopolamine butylbromide 10 mg oral tablet) ACCEL PHARMA INC | ACCEL-HYOSCINE (butylbromure de scopolamine 10 mg comprimé oral) ACCEL PHARMA INC | ACCEL-HYOSCINE (hyoscine butylbromide 10 mg oral tablet) ACCEL PHARMA INC | ACCEL-HYOSCINE (butylbromure d'hyoscine 10 mg comprimé oral) ACCEL PHARMA INC |
MP | 00363812 | BUSCOPAN (scopolamine butylbromide 10 mg oral tablet) SANOFI CONSUMER HEALTH INC | BUSCOPAN (butylbromure de scopolamine 10 mg comprimé oral) SANOFI CONSUMER HEALTH INC | BUSCOPAN (hyoscine butylbromide 10 mg oral tablet) SANOFI CONSUMER HEALTH INC | BUSCOPAN (butylbromure d'hyoscine 10 mg comprimé oral) SANOFI CONSUMER HEALTH INC |
MP | 00363839 | BUSCOPAN (scopolamine butylbromide 20 mg per 1 mL solution for injection ampoule) SANOFI CONSUMER HEALTH INC | BUSCOPAN (butylbromure de scopolamine 20 mg par 1 mL solution injectable ampoule) SANOFI CONSUMER HEALTH INC | BUSCOPAN (hyoscine butylbromide 20 mg per 1 mL solution for injection ampoule) SANOFI CONSUMER HEALTH INC | BUSCOPAN (butylbromure d'hyoscine 20 mg par 1 mL solution injectable ampoule) SANOFI CONSUMER HEALTH INC |
MP | 02229868 | HYOSCINE BUTYLBROMIDE INJECTION SANDOZ STANDARD (scopolamine butylbromide 20 mg per 1 mL solution for injection vial) SANDOZ CANADA INCORPORATED | HYOSCINE BUTYLBROMIDE INJECTION SANDOZ STANDARD (butylbromure de scopolamine 20 mg par 1 mL solution injectable fiole) SANDOZ CANADA INCORPORATED | HYOSCINE BUTYLBROMIDE INJECTION SANDOZ STANDARD (hyoscine butylbromide 20 mg per 1 mL solution for injection vial) SANDOZ CANADA INCORPORATED | HYOSCINE BUTYLBROMIDE INJECTION SANDOZ STANDARD (butylbromure d'hyoscine 20 mg par 1 mL solution injectable fiole) SANDOZ CANADA INCORPORATED |
For information on why this change has occurred, please see https://infocentral.infoway-inforoute.ca/en/forum/214-medication-management/4565-change-in-ingredient-scopolamine-butylbromide-to-hyoscine-butylbromide-in-ccdd#7932
Non-proprietary Therapeutic Product (NTP)
There are 7 new deprecated concepts in this version resulting from dose form corrections.
ntp_code | ntp_formal_name | ntp_fr_description | Change | New ntp_code | New ntp_formal_name | New ntp_fr_description |
|---|---|---|---|---|---|---|
9004224 | desmopressin (desmopressin acetate) 120 mcg orodispersible tablet | desmopressine (acétate de desmopressine) 120 mcg comprimé orodispersible | Deprecated | 9014733 | desmopressin (desmopressin acetate) 120 mcg sublingual tablet | desmopressine (acétate de desmopressine) 120 mcg comprimé sublingual |
9004542 | desmopressin (desmopressin acetate) 240 mcg orodispersible tablet | desmopressine (acétate de desmopressine) 240 mcg comprimé orodispersible | Deprecated | 9014734 | desmopressin (desmopressin acetate) 240 mcg sublingual tablet | desmopressine (acétate de desmopressine) 240 mcg comprimé sublingual |
9005294 | desmopressin (desmopressin acetate) 25 mcg orodispersible tablet | desmopressine (acétate de desmopressine) 25 mcg comprimé orodispersible | Deprecated | 9014735 | desmopressin (desmopressin acetate) 25 mcg sublingual tablet | desmopressine (acétate de desmopressine) 25 mcg comprimé sublingual |
9005609 | desmopressin (desmopressin acetate) 50 mcg orodispersible tablet | desmopressine (acétate de desmopressine) 50 mcg comprimé orodispersible | Deprecated | 9014736 | desmopressin (desmopressin acetate) 50 mcg sublingual tablet | desmopressine (acétate de desmopressine) 50 mcg comprimé sublingual |
9004225 | desmopressin (desmopressin acetate) 60 mcg orodispersible tablet | desmopressine (acétate de desmopressine) 60 mcg comprimé orodispersible | Deprecated | 9014737 | desmopressin (desmopressin acetate) 60 mcg sublingual tablet | desmopressine (acétate de desmopressine) 60 mcg comprimé sublingual |
9004952 | zolpidem tartrate 10 mg orodispersible tablet | tartrate de zolpidem 10 mg comprimé orodispersible | Deprecated | 9014745 | zolpidem tartrate 10 mg sublingual tablet | tartrate de zolpidem 10 mg comprimé sublingual |
9005166 | zolpidem tartrate 5 mg orodispersible tablet | tartrate de zolpidem 5 mg comprimé orodispersible | Deprecated | 9014746 | zolpidem tartrate 5 mg sublingual tablet | tartrate de zolpidem 5 mg comprimé sublingual |
Questions, Concerns, Changes
Questions and concerns and suggestions for future consideration are welcomed and should be sent by e-mail at [email protected]